Safety and efficacy of the addition of bevacizumab (BV) to temozolomide (TMZ) and radiation therapy (RT) followed by BV, TMZ, and irinotecan (CPT-11) for newly diagnosed glioblastoma multiforme (GBM)

被引：0
|
作者：
Vredenburgh, J. J. [1 ]
Desjardins, A. [1 ]
Reardon, D. A. [1 ]
Peters, K. [1 ]
Herndon, J. E., II [1 ]
Kirkpatrick, J. [1 ]
Gururangan, S. [1 ]
Bailey, L. [1 ]
Friedman, A. H. [1 ]
Friedman, H. S. [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2015
引用
收藏
页数：2
相关论文
共 50 条
  • [1] BEVACIZUMAB (BV) IN COMBINATION TO TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, TMZ, AND IRINOTECAN (CPT-11) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM): A PHASE 2 TRIAL
    Desjardins, Annick
    Reardon, David A.
    Peters, Katherine B.
    Herndon, James
    Kirkpatrick, John
    Gururangan, Sridharan
    Sampson, John H.
    Friedman, Allan H.
    Friedman, Henry
    Vredenburgh, James J.
    [J]. NEURO-ONCOLOGY, 2009, 11 (05) : 634 - 634
  • [2] SURVIVAL AND TOXICITY UPDATE OF THE PHASE 2 TRIAL OF BEVACIZUMAB (BV) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, TMZ, AND IRINOTECAN (CPT-11) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) PATIENTS
    Desjardins, Annick
    Reardon, David A.
    Peters, Katherine B.
    Herndon, James E., II
    Kirkpatrick, John P.
    Friedman, Henry S.
    Vredenburgh, James J.
    [J]. NEURO-ONCOLOGY, 2010, 12 : 77 - 77
  • [3] Bevacizumab (BEV) in combination with temozolomide (TMZ) and radiation therapy (XRT) followed by BEV, TMZ, and irinotecan for newly diagnosed glioblastoma multiforme (GBM)
    Vredenburgh, J. J.
    Desjardins, A.
    Reardon, D. A.
    Peters, K.
    Kirkpatrick, J.
    Herndon, J. E.
    Marcello, J.
    Bailey, L.
    Threatt, S.
    Friedman, H. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Phase II trial for patients with newly diagnosed glioblastoma (GBM) treated with carmustine wafers followed by concurrent radiation therapy (RT), temozolomide (TMZ), and bevacizumab (BV), then followed by TMZ and BV post-RT.
    Ranjan, Tulika
    Peters, Katherine B.
    Vlahovic, Gordana
    Alderson, Lloyd M.
    Herndon, James Emmett
    McSherry, Frances
    Threatt, Stevie
    Sampson, John Howard
    Friedman, Allan H.
    Bigner, Darell D.
    Friedman, Henry S.
    Vredenburgh, James J.
    Desjardins, Annick
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Safety and efficacy of the addition of bevacizumab to temozolomide and radiation therapy followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma multiforme
    Vredenburgh, James J.
    Desjardins, Annick
    Peters, Katherine B.
    Reardon, David A.
    Herndon, James Emmett
    Coan, April D.
    Kirkpatrick, John
    Bailey, Leighann
    Threatt, Stevie
    Sampson, John Howard
    Friedman, Allan H.
    Friedman, Henry S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Temozolomide (TMZ) and bevacizumab (BV) as initial treatment for unresectable or multifocal glioblastoma multiforme (GBM)
    Peters, K.
    Desjardins, A.
    Reardon, D. A.
    Perry, S.
    Herndon, J. E., II
    Bailey, L.
    Friedman, A. H.
    Friedman, H. S.
    Bigner, D. D.
    Vredenburgh, J. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] IRINOTECAN (CPT11) AND TEMOZOLOMIDE (TMZ) AS ADJUVANT TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM): PRELIMINARY REPORT
    Gorender, E.
    Meirelles, P. L. J.
    Epelman, S.
    [J]. NEURO-ONCOLOGY, 2010, 12 (06) : II73 - II73
  • [8] Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy
    Quinn, Jennifer A.
    Jiang, Sara Xiaoyin
    Reardon, David A.
    Desjardins, Annick
    Vredenburgh, James J.
    Friedman, Allan H.
    Sampson, John H.
    McLendon, Roger E.
    Herndon, James E., II
    Friedman, Henry S.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2009, 95 (03) : 393 - 400
  • [9] Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy
    Jennifer A. Quinn
    Sara Xiaoyin Jiang
    David A. Reardon
    Annick Desjardins
    James J. Vredenburgh
    Allan H. Friedman
    John H. Sampson
    Roger E. McLendon
    James E. Herndon
    Henry S. Friedman
    [J]. Journal of Neuro-Oncology, 2009, 95 : 393 - 400
  • [10] The addition of bevacizumab to temozolomide and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly diagnosed glioblastoma multiforme (GBM).
    Friedman, Henry S.
    Desjardins, Annick
    Peters, Katherine B.
    Reardon, David A.
    Kirkpatrick, John
    Herndon, James Emmett
    Coan, April D.
    Bailey, Leighann
    Sampson, John Howard
    Friedman, Allan H.
    Vredenburgh, James J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345